Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salophen-10-carboxylate iron chelate is a specific iron complex belonging to the broader class of salophen iron chelates. Salophenes are organic compounds characterized by two Schiff's bases linking three aromatic moieties, commonly employed as ligands in coordination chemistry. Iron salophen complexes, including this derivative, have been investigated for their potential as anticancer agents. Their mechanism of action involves inducing DNA damage, such as single and double strand breaks, particularly in the presence of a reducing agent. This DNA cleavage is thought to occur through the generation of reactive oxygen species, possibly via a Fenton-like reaction. Studies have shown that iron(III)-salophene exhibits selective cytotoxic and anti-proliferative effects, for instance, in platinum-resistant ovarian cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Salophen-10-carboxylate iron chelate.